Pharmaceutical facilities combine hazardous materials with stringent GMP requirements. This guide addresses fire safety challenges in UK cleanrooms and pharmaceutical manufacturing.. Pharmaceutical Fire Safety Complexity Pharmaceutical facilities present a unique intersection of fire safety and process requirements: Flammable solvents used in drug manufacturing and formulation ATEX zones requiring explosion protection Cleanroom environments with restricted access and specialised HVAC GMP requirements that may conflict with fire safety measures High value products with significant business interruption exposure Regulatory oversight from both fire safety and medicines regulators Hazardous Materials Solvent Risks Common pharmaceutical solvents include: Ethanol, methanol, isopropanol (flammable liquids) Acetone, ethyl acetate (highly flammable) Dichloromethane (non flammable but toxic) Toluene, hexane (highly flammable) DSEAR Assessment Hazardous area classification for all solvent handling areas ATEX zone mapping (Zone 0, 1, 2 for gases; Zone 20, 21, 22 for dusts) Equipment selection appropriate to zone classification Ventilation design to prevent explosive atmosphere formation Electrostatic discharge prevention measures Powder Handling Active Pharmaceutical Ingredients (APIs) may form explosive dust clouds Particle size analysis for explosion risk assessment Containment and local exhaust ventilation Explosion relief venting for process equipment Grounding and bonding of all conductive components Cleanroom Fire Safety Challenges HVAC Conflicts Cleanroom HVAC systems maintain positive pressure and HEPA filtration Fire smoke will be distributed through HVAC if not properly managed Fire/smoke dampers in cleanroom ductwork must maintain room classification when closed Smoke detection in HVAC return air ducts Automatic HVAC shutdown on fire alarm (conflicts with containment requirements) Access Restrictions Gowning requirements delay evacuation Limited entry/exit points for contamination control Airlocks creating bottlenecks during evacuation Fire service access in cleanroom suits (impractical) Suppression Compatibility Water from sprinklers will contaminate cleanroom environment Pre action sprinkler systems preferred (no accidental water discharge) Clean agent gas suppression for high value areas (Novec 1230, FM 200) Product exposure to suppression agents β contamination assessment Fire Safety Strategy Detection Aspirating smoke detection (ASD) in cleanroom areas VESDA with very high sensitivity settings Duct mounted detection in HVAC system Heat detection in solvent storage and handling areas Flame detection (UV/IR) in open solvent processing areas Suppression Pre action sprinkler systems in cleanroom manufacturing areas Deluge systems for solvent storage and dispensing areas Clean agent gas suppression for server/control rooms and high value storage Foam suppression for bulk solvent storage areas Water mist for areas where water damage must be minimised Compartmentation Cleanroom structures often provide inherent fire resistance Pharmaceutical segregation requirements align with fire compartmentation Process equipment penetrations through fire rated elements Maintenance of fire stopping during equipment modifications Business Continuity Production Loss Impact Drug shortages from single source manufacturing disruption Regulatory re approval requirements after fire damage Clean room re qualification timescales (months to years) Supply chain obligations and penalty clauses Insurance considerations for pharmaceutical operations Magnus Opifex SEVEN LTD β UK's Leading Fire Safety & Fire Engineering Consultancy π magnus opifex.co.uk π +44 (0) 20 3488 1926 βοΈ info@magnusopifex.co.uk Founded by Daniel Sheridan, Magnus Opifex SEVEN LTD delivers award winning fire engineering, fire risk assessments, and building safety consultancy across the United Kingdom and internationally.